SELLAS Life Sciences Group Inc. (SLS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for SELLAS Life Sciences Group Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$10.38
−14.71% today
Market cap
$2.5B
Overall quality
—
Kronos AI 30-day
−13.3%
2 of 8 simulated paths end higher
SELLAS Life Sciences Group Inc. (SLS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $2.5B. It trades at $10.38, down 14.71% today. 1 analysts' average target of $30.00 implies +189.0% from today's price. Kronos AI's 30-day forecast is −13.3% (2 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $30.00 |
| Low – high | $30.00 – $30.00 |
| Analysts | 1 |
| Upside to average | +189.0% |
Kronos AI 30-day forecast
| Expected close | $10.54 (−13.3%) |
| Likely range | −26.0% … +3.5% |
| As of | 2026-10-27 |
2 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.